Connecticut 2013 Regular Session

Connecticut House Bill HB05484 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		General Assembly Committee Bill No. 5484
2	2		January Session, 2013 LCO No. 4385
3		-	~~_____HB05484GL____031413___~~_
	3	+	04385HB05484GL_
4	4		Referred to Committee on GENERAL LAW
5	5		Introduced by:
6	6		(GL)
7	7
8	8		General Assembly
9	9
10	10		Committee Bill No. 5484
11	11
12	12		January Session, 2013
13	13
14	14		LCO No. 4385
15	15
16		-	~~_____HB05484GL____031413___~~_
	16	+	04385HB05484GL_
17	17
18	18		Referred to Committee on GENERAL LAW
19	19
20	20		Introduced by:
21	21
22	22		(GL)
23	23
24	24		AN ACT CONCERNING HEALTH INSURANCE COVERAGE AND ABUSE-DETERRENT PRESCRIPTION MEDICATIONS.
25	25
26	26		Be it enacted by the Senate and House of Representatives in General Assembly convened:
27	27
28	28		Section 1. Section 38a-492i of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2014):
29	29
30	30		(a) Each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (10), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide access to a pain management specialist and coverage for pain treatment ordered by such specialist that may include all means medically necessary to make a diagnosis and develop a treatment plan including the use of necessary medications and procedures.
31	31
32	32		(b) (1) No such policy that provides coverage for prescription drugs shall require an insured to use, prior to using a brand name prescription drug prescribed by a licensed physician for pain treatment, any alternative brand name prescription drugs or over-the-counter drugs.
33	33
34	34		(2) Such policy may require an insured to use, prior to using a brand name prescription drug prescribed by a licensed physician for pain treatment, a therapeutically equivalent generic drug, unless: (A) The brand name prescription drug contains United States Food and Drug Administration approved abuse-deterrent labeling, and (B) the therapeutically equivalent generic drug does not contain such labeling.
35	35
36	36		(c) As used in this section, "pain" means a sensation in which a person experiences severe discomfort, distress or suffering due to provocation of sensory nerves, and "pain management specialist" means a physician who is credentialed by the American Academy of Pain Management or who is a board-certified anesthesiologist, physiatrist, neurologist, oncologist or radiation oncologist with additional training in pain management.
37	37
38	38		Sec. 2. Section 38a-518i of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2014):
39	39
40	40		(a) Each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (10), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide access to a pain management specialist and coverage for pain treatment ordered by such specialist that may include all means medically necessary to make a diagnosis and develop a treatment plan including the use of necessary medications and procedures.
41	41
42	42		(b) (1) No such policy that provides coverage for prescription drugs shall require an insured to use, prior to using a brand name prescription drug prescribed by a licensed physician for pain treatment, any alternative brand name prescription drugs or over-the-counter drugs.
43	43
44	44		(2) Such policy may require an insured to use, prior to using a brand name prescription drug prescribed by a licensed physician for pain treatment, a therapeutically equivalent generic drug, unless: (A) The brand name prescription drug contains United States Food and Drug Administration approved abuse-deterrent labeling, and (B) the therapeutically equivalent generic drug does not contain such labeling.
45	45
46	46		(c) As used in this section, "pain" means a sensation in which a person experiences severe discomfort, distress or suffering due to provocation of sensory nerves, and "pain management specialist" means a physician who is credentialed by the American Academy of Pain Management or who is a board-certified anesthesiologist, physiatrist, neurologist, oncologist or radiation oncologist with additional training in pain management.
47	47
48	48
49	49
50	50
51	51		This act shall take effect as follows and shall amend the following sections:
52	52		Section 1 January 1, 2014 38a-492i
53	53		Sec. 2 January 1, 2014 38a-518i
54	54
55	55		This act shall take effect as follows and shall amend the following sections:
56	56
57	57		Section 1
58	58
59	59		January 1, 2014
60	60
61	61		38a-492i
62	62
63	63		Sec. 2
64	64
65	65		January 1, 2014
66	66
67	67		38a-518i
68	68
	69	+	Statement of Purpose:
	70	+
	71	+	To reduce prescription medication abuse.
	72	+
	73	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
69	74
70	75
71		-	GL Joint Favorable
72	76
73		-	GL
	77	+	Co-Sponsors: REP. CARTER, 2nd Dist.; REP. COOK, 65th Dist. REP. SRINIVASAN, 31st Dist.
74	78
75		-	Joint Favorable
	79	+	Co-Sponsors:
	80	+
	81	+	REP. CARTER, 2nd Dist.; REP. COOK, 65th Dist.
	82	+
	83	+	REP. SRINIVASAN, 31st Dist.
	84	+
	85	+	H.B. 5484